Presentation is loading. Please wait.

Presentation is loading. Please wait.

Recombinant Activated Factor VII in Cardiac Surgery: Experience From the Australian and New Zealand Haemostasis Registry  Scott Dunkley, BMed, FRACP,

Similar presentations


Presentation on theme: "Recombinant Activated Factor VII in Cardiac Surgery: Experience From the Australian and New Zealand Haemostasis Registry  Scott Dunkley, BMed, FRACP,"— Presentation transcript:

1 Recombinant Activated Factor VII in Cardiac Surgery: Experience From the Australian and New Zealand Haemostasis Registry  Scott Dunkley, BMed, FRACP, Louise Phillips, BSc (Hons), PhD, Peter McCall, MBBS, FANZCA, John Brereton, MBBS, FRACS, Robert Lindeman, MBBS (Hons), BSc (Med), Gary Jankelowitz, MBBch, MBA, Peter Cameron, MBBS, MD  The Annals of Thoracic Surgery  Volume 85, Issue 3, Pages (March 2008) DOI: /j.athoracsur Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Effect of activated recombinant factor VII on bleeding versus outcome (deceased, vertical pattern; living, diagonal pattern) at 28 days (χ22 = 22.3; p < 0.001). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2008 The Society of Thoracic Surgeons Terms and Conditions


Download ppt "Recombinant Activated Factor VII in Cardiac Surgery: Experience From the Australian and New Zealand Haemostasis Registry  Scott Dunkley, BMed, FRACP,"

Similar presentations


Ads by Google